The expression level of NCOA5 in FIGO stage III/IV was significantly higher than that in FIGO stage I/II patients, indicating that NOCA5 may play a role in the distant metastasis of ovarian cancer, however, it needs to be verified by cell experiments. Here, NCOA5 is linked to ovarian carcinoma.